Hundreds of industry leaders have signed a letter to FDA director Marty Makary, M.D., about the importance of having a ...

The CDC is instructing scientists to end all research involving monkeys by the end of the year, in a move that will ...

The FDA says it is hiring more than 1,000 new employees and rolling out a pilot communication program in efforts to speed up ...

Roche has claimed the exclusive international rights to Freenome’s multiomic cancer screening approaches, toward the goal of ...

The Fierce team will be out of office next Friday for the Thanksgiving holiday. The next edition of Chutes & Ladders will ...

Nurix Therapeutics is trimming its workforce not long after launching a pivotal phase 2 trial for its lead cancer asset. | ...

Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. | Contineum Therapeutics’ M1 receptor ...

GE HealthCare plans to pay $2.3 billion in cash to acquire imaging software developer Intelerad, toward the goal of building ...

With much of Moderna’s recent rise tied to its COVID-19 vaccine, the company has struggled to match the sales highs it ...

When Tim Hunt was invited to a meeting with Robert F. Kennedy Jr. in early March, the Department of Health and Human Services (HHS) secretary had only been sworn in a few weeks earlier. | When Tim ...

The Cooper Companies have recently faced pressure from activist investors on two fronts, with pushes to split up their businesses as well as reshape their board of directors.  | Activist investors ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...